Skip to content

Clinical trials

Phase 1 Neoplasm Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1 Clear all

946 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20019
20023
20037
200415
200517
200626
200724
200830
200930
201039
201142
201237
201339
201434
201530
201649
201736
201835
201939
202044
202161
202252
202359
202458
202555
202639

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed455
Terminated159
Recruiting157
Active, not recruiting65
Unknown status49
Withdrawn30
Not yet recruiting23
Suspended7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)69
Eli Lilly and Company43
M.D. Anderson Cancer Center41
Memorial Sloan Kettering Cancer Center17
Pfizer16
AstraZeneca15
Novartis Pharmaceuticals15
H. Lee Moffitt Cancer Center and Research Institute14
City of Hope Medical Center10
Merck Sharp & Dohme LLC9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis946
Neoplasms233
Carcinoma, Non-Small-Cell Lung131
Breast Neoplasms130
Colorectal Neoplasms121
Melanoma97
Pancreatic Neoplasms78
Ovarian Neoplasms76
Lung Neoplasms75
Recurrence66

Trials

Showing 1 to 25 of 946. Each trial links to its page on Pharma Observatory.

846 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.